Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.

Background And Objectives: A large number of patients with thalassemia major have been born and treated exclusively in Cyprus. They have been managed according to standard international practice, but few have been transplanted. In 1999, a combination chelation regime with desferrioxamine and deferiprone was introduced.